Schedule 13D ownership disclosure
IDERA PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45168K306
Event date: 2022-06-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-181610
- Form type
- SC 13D
- Filer
- Aceragen, Inc.
- CIK
- CIK 861838
- Filed
- Jun 24, 2022
- Reporting period
- Jun 09, 2022
- Description
- Schedule 13D beneficial ownership